Micronutrients & recovery
Increasing dietary intake of omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs) and maintaining an omega-6/omega-3 ratio of 2–4:1 is associated with a reduced risk of breast, prostate, colon, and renal cancers.
To support cancer prevention and overall health, aim to consume 2-3 servings of oily fish weekly to get 200-500 mg of EPA/DHA daily. If you have existing cardiovascular risks, medical guidance may suggest 1-4 grams daily. Crucially, try to lower your omega-6 to omega-3 ratio from the typical Western 20:1 down to 2-4:1 by reducing processed seed oils and increasing omega-3 sources.
Recent findings reviewed in the present study highlight that the omega-6 fatty acid ARA appears increased, and omega-3 EPA and DHA decreased in most cancer tissues compared to normal ones, and that increments in omega-3 LC-PUFAs consumption and an omega-6/omega-3 ratio of 2–4:1, are associated with a reduced risk of breast, prostate, colon and renal cancers.
Why this rating
The paper is a review summarizing observational and clinical data; it notes mixed results in recent trials for other conditions, suggesting moderate certainty for cancer specifically based on ratio associations.
Source
Significance of long chain polyunsaturated fatty acids in human health
Rafael Zárate et al. · Clinical and Translational Medicine · 2017
DOI 10.1186/s40169-017-0153-6
More from this paper
- Omega-3 LC-PUFAs (EPA/DHA) lower fasting plasma triglyceride (TG) levels by 29% in individuals with levels >150 mg/dL when taken at doses of 3.4–4 g/day, primarily by inhibiting de novo lipogenesis via SREBP1c regulation.Good
- Omega-3 LC-PUFAs exert anti-inflammatory effects by generating specialized pro-resolving mediators (SPMs) like resolvins, protectins, and maresins, which actively promote the resolution of inflammation rather than just suppressing it.Good
Related findings · Micronutrients & recovery
- Trans fats (industrial trans-fatty acids) are unequivocally harmful and should be completely avoided as they raise LDL-C, TGs, and Apo B while lowering HDL-C.Strong
- For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.Strong
- Folic acid fortification of flour prevents neural tube birth defects, and mandatory fortification is more effective than voluntary supplementation alone.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →